Noted: AIQ Solutions was formed by UW Madison researchers who pioneered methods to quantitatively assess changes in cancerous bone lesions in response to cancer treatment. On campus, they received early support from Discovery to Product’s Igniter program and the Wisconsin Alumni Research Foundation as the founders worked to commercialize their medical device technology platform, which is based on advanced analytics and artificial intelligence. AIQ Solutions has just completed a $3.2M Series A funding round, a major milestone which will help the company market its first product offering and develop additional applications for its underlying technology. Congratulations, AIQ team!
Read the full article at: https://xconomy.com/wisconsin/2019/08/07/aiq-solutions-hits-on-3-2m-to-pinpoint-drug-resistant-tumors/
A network for inventors & entrepreneurs